PT1408977E - Terapia de combinacao para o tratamento de falha cardiaca - Google Patents

Terapia de combinacao para o tratamento de falha cardiaca

Info

Publication number
PT1408977E
PT1408977E PT02743321T PT02743321T PT1408977E PT 1408977 E PT1408977 E PT 1408977E PT 02743321 T PT02743321 T PT 02743321T PT 02743321 T PT02743321 T PT 02743321T PT 1408977 E PT1408977 E PT 1408977E
Authority
PT
Portugal
Prior art keywords
combination therapy
cardiac failure
failure treatment
combination
heart failure
Prior art date
Application number
PT02743321T
Other languages
English (en)
Inventor
Haikala Heimo
Poeder Pentti
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of PT1408977E publication Critical patent/PT1408977E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • External Artificial Organs (AREA)
  • Laser Surgery Devices (AREA)
PT02743321T 2001-07-04 2002-07-04 Terapia de combinacao para o tratamento de falha cardiaca PT1408977E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011464A FI20011464A0 (fi) 2001-07-04 2001-07-04 Yhdistelmäterapia sydämen vajaatoiminnan hoitoon

Publications (1)

Publication Number Publication Date
PT1408977E true PT1408977E (pt) 2005-08-31

Family

ID=8561589

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02743321T PT1408977E (pt) 2001-07-04 2002-07-04 Terapia de combinacao para o tratamento de falha cardiaca

Country Status (10)

Country Link
US (1) US6949548B2 (pt)
EP (1) EP1408977B1 (pt)
JP (2) JP2004535463A (pt)
AT (1) ATE297732T1 (pt)
CA (1) CA2450915C (pt)
DE (1) DE60204694T2 (pt)
ES (1) ES2243740T3 (pt)
FI (1) FI20011464A0 (pt)
PT (1) PT1408977E (pt)
WO (1) WO2003007962A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
AU2003251627A1 (en) 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
MXPA04012923A (es) 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
EP1612204A4 (en) * 2003-03-31 2007-04-11 Daiichi Seiyaku Co HYDRAZONE DERIVATIVE
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
JP2008530186A (ja) * 2005-02-18 2008-08-07 オリオン コーポレーション 心不全治療法
US20080070917A1 (en) * 2005-02-18 2008-03-20 Thakkar Roopal B Methods for administering levosimendan
US20130130869A1 (en) * 2011-11-22 2013-05-23 Kuang-Hua HOU Platform for supporting conveyor belt of treadmill
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5998458A (en) 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure

Also Published As

Publication number Publication date
ES2243740T3 (es) 2005-12-01
EP1408977A1 (en) 2004-04-21
EP1408977B1 (en) 2005-06-15
DE60204694T2 (de) 2006-05-11
CA2450915C (en) 2010-09-28
JP2010065060A (ja) 2010-03-25
JP2004535463A (ja) 2004-11-25
US6949548B2 (en) 2005-09-27
ATE297732T1 (de) 2005-07-15
DE60204694D1 (de) 2005-07-21
CA2450915A1 (en) 2003-01-30
FI20011464A0 (fi) 2001-07-04
WO2003007962A1 (en) 2003-01-30
US20040209885A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
PT1173178E (pt) Composicao compreendendo apomorfina e sildenafil e utilizacao da mesma para o tratamento da disfuncao erectil
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
WO2000064441A3 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
BR0115162A (pt) Tratamentos antitumorais eficazes
ATE493981T1 (de) Einmal tägliche dosierformen von trospium
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
FI20011464A0 (fi) Yhdistelmäterapia sydämen vajaatoiminnan hoitoon
ATE306267T1 (de) Kombinationsbehandlung bei akutem myokardinfarkt
NO20055531L (no) Preparat for forbedret kognisjon og hukommelse
RU2002117537A (ru) Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии
SE9902597D0 (sv) New use
EA200500427A1 (ru) Способы лечения пациентов, страдающих синдромом усталых ног или связанными с ним заболеваниями
WO2001080895A3 (en) Methods and compositions for the treatment of cardiac indications
GB9930077D0 (en) Medicaments
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
DK1265629T3 (da) Anvendelse af væksthormon i lav dosis
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
CO5170404A1 (es) Terapia para melanomas
NO20043774L (no) The use of devazenide as analgesic agent